Constructing and validating pan-apoptosis-related features for predicting prognosis and immunotherapy response in hepatocellular carcinoma
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150633 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Yuhong He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Hepatobiliary Surgery, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China; Hepatobiliary Rela…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Apoptosis, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The study aimed to develop a prognostic model for Hepatocellular Carcinoma (HCC) based on pan-apoptosis-related genes, a novel inflammatory programmed cell death form intricately linked to HCC progression. Utilizing transcriptome sequencing and clinical data from the TCGA database, we identified six crucial pan-apoptosis-related genes through statistical analyses. These genes were then employed to construct a prognostic model that accurately predicts overall survival rates in HCC patients. Our findings revealed a strong correlation between the model's risk scores and tumor microenvironment (TME) status, immune cell infiltration, and immune checkpoint expression. Furthermore, we screened for drugs with potential therapeutic efficacy in high- and low-risk HCC groups. Notably, PPP2R5B gene knockdown was found to inhibit HCC cell proliferation and clonogenic capacity, suggesting its role in HCC progression. In conclusion, this study presents a novel pan-apoptosis gene-based prognostic risk model for HCC, providing valuable insights into patient TME status and guiding the selection of targeted therapies and immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Hepatobiliary Surgery, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China; Hepatobiliary Related Diseases Key Laboratory of Zhanjiang, Zhanjiang, 524001, Guangdong…
- Hepatobiliary Surgery, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China. Electronic address: 1044486429@qq.com.
- Hepatobiliary Surgery, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China. Electronic address: 99276298@qq.com.
- Hepatobiliary Surgery, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China. Electronic address: anwan4571@163.com.
- Clinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China. Electronic address: wujiay@gdmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
He, Y., Wu, S., Chen, L., Chen, W., Zhan, X., Li, J., Wang, B., Gao, C., Wu, J., Wang, Q., Li, M., & Liu, B. (2024). Constructing and validating pan-apoptosis-related features for predicting prognosis and immunotherapy response in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150633
Vancouver
He Y, Wu S, Chen L, Chen W, Zhan X, Li J, et al. Constructing and validating pan-apoptosis-related features for predicting prognosis and immunotherapy response in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150633
BibTeX
@article{He2024,
author = {He, Yuhong and Wu, Shihao and Chen, Lifan and Chen, Wenxia and Zhan, Xiumei and Li, Jiaxing and Wang, Bingyuan and Gao, Chenfeng and Wu, Jiayuan and Wang, Qingwei and Li, Mingyi and Liu, Bin},
title = {Constructing and validating pan-apoptosis-related features for predicting prognosis and immunotherapy response in hepatocellular carcinoma},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150633}
}
EUVIMED